Cory R. Weissman, MD

JCP
rTMS for Treatment-Resistant Depression: Mismatch of Evidence and Insurance Coverage Policies
Commentary

April 26, 2023

The authors argue that insurance companies’ prior authorization process overly restricts access to rTMS, which has proven effectiveness for TRD.
Cory R. Weissman, Richard A. Bermudes, Jeffrey Voigt, et al
JCP
Corrigendum to “Decreases in Suicidality Following Psychedelic Therapy: A Meta-Analysis of Individual Patient Data Across Clinical Trials”
Letter to the Editor

May 9, 2022

The authors note two suicidality-related events that occurred within the studies included in their recent meta-analysis.
Richard J. Zeifman, Dengdeng Yu, Nikhita Singhal, et al
JCP
Meta-Analysis

January 18, 2022

Psychedelic therapy shows promise for a range of mental health concerns, including suicidality. This meta-analysis is the first to systematically examine the effects of psychedelic therapy on suicidality.
Richard J. Zeifman, Dengdeng Yu, Nikhita Singhal, et al
JCP
Meta-Analysis

January 18, 2022

Repetitive magnetic transcranial stimulation (rTMS) has been established as an efficacious treatment for MDD. This meta-analysis looked at its effects on suicidal ideation in depressed patients across the lifespan.
Shobha Mehta, Gerasimos Konstantinou, Cory R. Weissman, et al
JCP
Original Research

April 17, 2018

Read a study on the effects of rTMS on suicidal ideation in patients with treatment-resistant major depression (TRD).
Cory R. Weissman, Daniel M. Blumberger, Patrick E. Brown, et al

Celebrating
85 Years

Read the Journal of Clinical Psychiatry

Subscribe to read
more articles

Subscribe